DOSSIER · 13F Holders · Q2 2026Healthcare · In Vitro & In Vivo Diagnostic Substances
CLDX
CELLDEX THERAPEUTICS INC NEW
268 institutions still hold CELLDEX THERAPEUTICS INC NEW as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 15117B202·In Vitro & In Vivo Diagnostic Substances·268 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
268 institutions reported CLDX in Q2 2026. WELLINGTON MANAGEMENT GROUP LLP leads at 16.9% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 14
248 more holders available. Log in →